The major goal of THE JOURNAL is to publish the very best articles possible
to advance medical science and expand medical knowledge, thereby enabling
physicians and other health care professionals to provide the most up-to-date,
scientific, evidence-based care for patients. The recently published report
from the National Heart, Lung, and Blood Institute (NHLBI) Women's Health
Initiative (WHI)1 illustrates the importance
of providing solid evidence from rigorously conducted clinical trials that
has the potential to change clinical practice—in this case, involving
use of estrogen-plus-progestin hormone therapy. Moreover, the unexpected findings
of the WHI investigation, that this major primary prevention trial was stopped
early because the risks of combination estrogen-plus-progestin therapy outweighed
the benefits for postmenopausal women, have implications for millions of women
taking hormone therapy. Thus, it was virtually inevitable that the study results
would generate intense interest among clinicians and widespread attention
from the news media and the public.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 7
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.